$tr2['classname']

肺癌

$tr2['classname']

乳腺癌

$tr2['classname']

结直肠癌

$tr2['classname']

前列腺癌

$tr2['classname']

甲状腺癌

$tr2['classname']

宫颈癌

$tr2['classname']

胃癌

$tr2['classname']

肝癌

$tr2['classname']

胆囊癌

$tr2['classname']

卵巢癌

$tr2['classname']

食管癌

$tr2['classname']

胰腺癌

$tr2['classname']

膀胱癌

$tr2['classname']

淋巴瘤

$tr2['classname']

子宫内膜癌

$tr2['classname']

肾癌

$tr2['classname']

罕见肿瘤

首页 > TAG信息列表 > PD-1耐药

免疫治疗|癌症疫苗

PD-1耐药的新希望!肿瘤疫苗Tedopi(OSE-2101)在非小细胞肺癌(NSCLC)III

靶点|LAG-3

揭示PD-1耐药机制 ,LAG-3靶点再引关注
  • 揭示PD-1耐药机制 ,LAG-3靶点再引关注
  •   以CTLA-4、PD-1、PD-L1三个免疫检查点的多款单抗为代表的肿瘤免疫治疗药物,广泛应用于多种肿瘤治疗领域。然而,对于部分肿瘤而言,PD-1/L1抑制剂只对20%~30%的患者有效,在这...|阅读全文
  • 发布日期 2020-07-26 09:28:58